Literature DB >> 6378445

Pathogenesis and pathophysiology of duodenal ulcer.

S K Lam.   

Abstract

Much epidemiological, clinical, and pathophysiological evidence has accumulated to indicate that the aetiology of duodenal ulcer is heterogeneous (Table 8). Recent advances in the medical therapy of duodenal ulcer support the long held concept that hyperacidity is an important physiological abnormality in the majority of patients with duodenal ulcer. It can also be shown that the origin of hyperacidity is heterogeneous. Certain specific physiological abnormalities that lead to hyperacidity may have a genetic basis. The various physiological abnormalities, alone or in combination, may lead to two final common pathways: abnormally large meal-stimulated acid secretion, and nocturnal acid hypersecretion. Indeed, success of medical therapy aiming at the control of postprandial acid secretion or of nocturnal acid secretion strongly supports their significance. It is possible that hyperacidity occurs as a temporary phenomenon and is associated with stressful life events. However, it is also possible that it occurs as a constant abnormality, bestowed perhaps genetically on the duodenal ulcer patient. In the presence of hyperacidity, mucosal repair may be affected adversely. In either situation, an acute ulcer, such as that associated with stress, is allowed to develop into a full-blown ulcer. Healing takes place if the hyperacidity recedes or is reduced therapeutically, allowing normal mucosal repair to take place.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378445

Source DB:  PubMed          Journal:  Clin Gastroenterol        ISSN: 0300-5089


  23 in total

1.  Mealtime versus nighttime acid inhibition. A clinical pharmacological study with ranitidine.

Authors:  V Savarino; G S Mela; P Zentilin; S Vigneri; P Cutela; R Mele; F Di Mario
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

2.  A comparative study of once-a-day morning and once-a-day bedtime administration of 40 mg famotidine in treating duodenal ulcers.

Authors:  M Okada; M Arita; M Iida; T Yao; T Sakurai; K Hoshiko; K Maeda; Y Okada; K Sakamoto
Journal:  Gastroenterol Jpn       Date:  1992-04

3.  Gastric metaplasia and Helicobacter pylori infection.

Authors:  V Savarino; G S Mela; G Celle; S Vigneri
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

4.  Gastric acid secretion and gastric emptying of liquids in 99 male duodenal ulcer patients.

Authors:  R Corinaldesi; V Stanghellini; G F Paparo; A Paternicò; A Giulia Rusticali; L Barbara
Journal:  Dig Dis Sci       Date:  1989-02       Impact factor: 3.199

5.  Effect of duodenal ulcerogens cysteamine, mepirizole, and MPTP on duodenal myoelectric activity in rats.

Authors:  J C Mangla; G Pihan; H A Brown; S Rattan; S Szabo
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

6.  24-hour study of intragastric acidity in duodenal ulcer patients and normal subjects using continuous intraluminal pH-metry.

Authors:  V Savarino; G S Mela; P Scalabrini; A Sumberaz; G Fera; G Celle
Journal:  Dig Dis Sci       Date:  1988-09       Impact factor: 3.199

7.  Pepsinogen genetics and duodenal ulcer disease.

Authors:  J I Rotter; I M Samloff; G M Petersen
Journal:  Gut       Date:  1986-02       Impact factor: 23.059

8.  Effect of partial gastrectomy with Billroth II or Roux-en-Y anastomosis on postprandial and cholecystokinin-stimulated gallbladder contraction and secretion of cholecystokinin and pancreatic polypeptide.

Authors:  P N Rieu; J B Jansen; W P Hopman; H J Joosten; C B Lamers
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

9.  The pathophysiology of peptic ulcer disease.

Authors:  F P Brooks
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

10.  Acid perfusion of duodenal ulcer craters and ulcer pain: a controlled double blind study.

Authors:  J Y Kang; I Yap; R Guan; H H Tay
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.